Clinical trial
Drug Study of Albuterol to Treat Acute Lung Injury
NCT00434993 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00434993 |
|---|---|
| Title | Drug Study of Albuterol to Treat Acute Lung Injury |
| Official title | Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo in Acute Lung Injury |
| Acronym | ALTA |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Adult |
| Intervention type | Drug, Procedure |
| Interventions | Albuterol Sulfate, Mini-Bronchoalveolar Lavage (BAL), Placebo |
| Enrollment | 282 |
| Start date | Aug 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Feb 14, 2007 |
| Last update posted | Feb 10, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: